Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte–macrophage colony‐stimulating factor for murine ovarian cancer

Fumi Goshima(Nagoya University), Yukihiro Nishiyama(Nagoya University)

International Journal of Cancer

November 22, 2013

10.1002/ijc.28631

Cited by 34

Related Papers

Herpes simplex virus induces the marked up-regulation of the zinc finger transcriptional factor INSM1, which modulates the expression and localization of the immediate early protein ICP0

|Virology Journal|2011|9